Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Camden Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Camden Asset Management
from 13F filings
Historical chart of Camden Asset Management investment in Halozyme Therapeutics Inc Note 1.000 8/1
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Camden Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Camden Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $50B | 35M | 1405.00 |
| 2025-06-30 | $77B | 68M | 1138.50 |
| 2025-03-31 | $61B | 48M | 1278.83 |
| 2024-12-31 | $81B | 76M | 1078.41 |
| 2024-09-30 | $75B | 63M | 1187.50 |
| 2024-06-30 | $48B | 44M | 1111.59 |
| 2024-03-31 | $30B | 31M | 971.55 |
| 2023-12-31 | $12B | 13M | 926.50 |
| 2023-09-30 | $12B | 13M | 933.75 |
Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1
View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1